DORO

Doro

Market Cap 1,088.0M

Doro is a more than 40 years old Small Cap company, developing and manufacturing telecommunication products for seniors (people with the age of 65 or older) since year 2007. The products, typically traditional feature phones and smartphones, are sold in more than 30 countries. Doro’s leading position is based on a wide and global distribution network and a strong brand that the target group can trust. This has resulted in a niche market share of some 50 percent in Western Europe, but Doro is number one in several other markets as well. The major weakness in the business model is that Doro sells hardware with short life cycles and is dependent on constantly developing better products. However, Doro is increasingly focusing on growing the Care area, i.e. telecare and mobile health, meaning recurring service revenue.

+ more

Redeye Research

Reports

Notes

Today
Day High
46.00
45.6
Day Low
45.60
Day Open
45.40
Prev Close
45.80
VWAP
45.7
Volume
8K
Turnover
0.387M
Top Broker
ENS
VWAP
45.6
Avg Volume
21K
Avg Turnover
0.975M
Top Brokers
AVA/ENS
VWAP
45.3
Avg Volume
39K
Avg Turnover
1.761M
Top Brokers
AVA/NON
VWAP
46.7
Avg Volume
38K
Avg Turnover
1.753M
Top Brokers
AVA/NON
52 week summary
Price Range
43.6
Last
62.8
Beta
N/A
Market Cap
1,088.0M
Total Return
-12.5%
Trailing P/E
35.1
Div Yield
2.2%
Shares Outstanding
23.8M
Next Earnings Date
15 Feb
Stock Exchange
NASDAQ Stockholm
5 day chart Go to advanced chart

Identify and measure trend strength in stocks with our Momentum tool to identify potential entry and exit signals. The tool provides a set of the most simple but powerful indicators that identify whether a stock is under sell or buy pressure.


Relative Price Strength
Change 3 Months -10.6%
Change 12 Months -22.1%
Volume Trend
Average Volume 10 vs 60 Days -12.6%
Price VS
52 Week High -27.3%
50 Day Moving Average -7.5%
200 Day moving Average -12.4%

Add article markers

Compare Doro to

Prev Close 0 Change 0
High 0 Avg Daily Volume 0
Low 0 Avg Daily Turnover 0
  • Management
  • Robert Puskaric, CEO
  • Carl-Johan Zetterberg Boudrie, CFO
  • Executive board
  • Johan Andsjö, Chairman of the board
Last updated: 2017-10-28 Source: Redeye
Major Owners Equity Votes
Accendo Capital 14.0%
14.0%
Rite Ventures 8.1%
8.1%
Humle Fonder 3.5%
3.5%
Origo Fonder 3.4%
3.4%
Avanza Pension 3.2%
3.2%
Nordea Fonder 3.1%
3.1%
Dimensional Fund Advisors 2.6%
2.6%
Bengt Julander 2.5%
2.5%
Theodor Jeansson 2.3%
2.3%
Thomas Eklund 1.7%
1.7%
Last updated: 2017-10-14 Source: Redeye/Holdings
Timeframe Transactions Net Shares
Last 12 weeks
4 Purchases
+ 14,550
1 Sales
- 1,250
Last 24 weeks
4 Purchases
+ 14,550
1 Sales
- 1,250
Report Date Name Position Transaction Shares Chg Est Value (SEK)

Catalyst Potential is behind membership

To access members-only content, you must login or register an account.

Our membership is about gaining access to unique research and knowledge through our analysts and a network of peers. Be the first to get information about news and research in the Nordic life science and technology sectors and use our tools and education to reach your personal and professional goals in investing.

Source: Millistream FI
  •  
  • Profitability
  • ROE
  • ROCE
  • ROIC
  • EBITDA margin
  • EBIT margin
  • Net margin
  • Per share data (SEK)
  • EPS
  • EPS adj
  • Dividend
  • Net debt
  • Total shares
  • Valuation
  • EV (SEKm)
  • P/E
  • P/E diluted
  • P/Sales
  • EV/Sales
  • EV/EBITDA
  • EV/EBIT
  • P/BV
  • Capital structure
  • Equity ratio
  • Debt/equity ratio
  • Net debt(SEKm)
  • Capital employed(SEKm)
  • Capital turnover rate
  • (SEKm)
  • Net sales
  • Total operating costs
  • EBITDA
  • Depreciation
  • Amortization
  • Impairment charges
  • EBIT
  • Share in profits
  • Net financial items
  • Exchange rate dif.
  • Pre-tax profit
  • Tax
  • Net earnings
  • (SEKm)
  • Assets
  • Current assets
  • Cash in banks
  • Receivables
  • Inventories
  • Other current assets
  • Current assets
  • Fixed assets
  • Tangible assets
  • Associated comp.
  • Investments
  • Goodwill
  • Cap. exp. for dev.
  • O intangible rights
  • O non-current assets
  • Total fixed assets
  • Deferred tax assets
  • Total (assets)
  • Liabilities
  • Current liabilities
  • Short-term debt
  • Accounts payable
  • O current liabilities
  • Current liabilities
  • Long-term debt
  • O long-term liabilities
  • Convertibles
  • Total Liabilities
  • Deferred tax liab
  • Provisions
  • Shareholders' equity
  • Minority interest (BS)
  • Minority & equity
  • Total liab & SE
  • (SEKm)
  • Net sales
  • Total operating costs
  • Depreciations total
  • EBIT
  • Taxes on EBIT
  • NOPLAT
  • Depreciation
  • Gross cash flow
  • Change in WC
  • Gross CAPEX
  • Free cash flow
  • 2014
  •  
  • 18.7%
  • 24.6%
  • 30.5%
  • 10.1%
  • 6.8%
  • 4.6%
  •  
  • 2.76
  • 2.76
  • 0.00
  •  
  • 21.1
  •  
  • 780.4
  • 14.0
  • 14.0
  • 0.6
  • 0.6
  • 6.0
  • 9.0
  • 2.4
  •  
  • 39.3%
  • 4.9%
  • -37
  • 298
  • 1.5
  • 2014
  •  
  •  
  • 78
  • 316
  • 205
  • 32
  • 630
  •  
  • 5
  • 0
  • 0
  • 152
  • 0
  • 49
  • 1
  • 207
  • 16
  • 853
  •  
  •  
  • 0
  • 252
  • 165
  • 417
  • 42
  • 3
  • 0
  • 461
  • 0
  • 57
  • 335
  • 0
  • 335
  • 853
  • 2014
  • 1,277
  • -1,148
  • -43
  • 87
  • -23
  • 63
  • 43
  • 106
  • -20
  • -43
  • -90
  • 2014 Q4
  • 437
  • -381
  • 56
  • -18
  • 0
  • 0
  • 38
  • 0
  • -5
  • 0
  • 33
  • -11
  • 22
  • 2015
  •  
  • 15.6%
  • 17.5%
  • 24.1%
  • 8.1%
  • 5.2%
  • 3.5%
  •  
  • 2.75
  • 2.75
  • 0.00
  •  
  • 23.2
  •  
  • 1,625.4
  • 22.6
  • 22.6
  • 0.8
  • 0.9
  • 10.9
  • 17.1
  • 3.0
  •  
  • 40.2%
  • 13.7%
  • 185
  • 667
  • 1.5
  • 2015
  •  
  •  
  • 44
  • 452
  • 189
  • 33
  • 717
  •  
  • 8
  • 0
  • 0
  • 349
  • 20
  • 75
  • 15
  • 466
  • 16
  • 1,199
  •  
  •  
  • 58
  • 287
  • 168
  • 512
  • 170
  • 0
  • 0
  • 683
  • 0
  • 34
  • 482
  • 0
  • 482
  • 1,199
  • 2015
  • 1,838
  • -1,689
  • -54
  • 95
  • -23
  • 72
  • 54
  • 126
  • -84
  • -313
  • -147
  • 2015 Q1
  • 340
  • -353
  • -13
  • -10
  • -3
  • 0
  • -23
  • 0
  • -6
  • 0
  • -28
  • 6
  • -22
  • 2015 Q2
  • 426
  • -387
  • 39
  • -10
  • -3
  • 0
  • 29
  • 0
  • -2
  • 0
  • 27
  • -6
  • 21
  • 2015 Q3
  • 447
  • -408
  • 39
  • -9
  • -2
  • 0
  • 30
  • 0
  • -1
  • 0
  • 29
  • -7
  • 22
  • 2015 Q4
  • 626
  • -542
  • 84
  • -25
  • -3
  • 0
  • 59
  • 0
  • -2
  • 0
  • 57
  • -14
  • 42
  • 2016
  •  
  • 6.0%
  • 6.4%
  • 5.5%
  • 6.1%
  • 2.4%
  • 1.5%
  •  
  • 1.30
  • 1.30
  • 1.00
  •  
  • 23.2
  •  
  • 1,405.1
  • 40.7
  • 40.7
  • 0.6
  • 0.7
  • 11.6
  • 29.9
  • 2.4
  •  
  • 40.4%
  • 16.0%
  • 174
  • 694
  • 1.5
  • 2016
  •  
  •  
  • 61
  • 438
  • 218
  • 75
  • 792
  •  
  • 13
  • 0
  • 0
  • 372
  • 19
  • 73
  • 7
  • 484
  • 12
  • 1,288
  •  
  •  
  • 72
  • 255
  • 193
  • 520
  • 162
  • 35
  • 0
  • 717
  • 0
  • 51
  • 520
  • 0
  • 520
  • 1,288
  • 2016
  • 1,969
  • -1,848
  • -74
  • 47
  • -10
  • 37
  • 74
  • 110
  • -64
  • -92
  • 10
  • 2016 Q1
  • 416
  • -394
  • 22
  • -13
  • -2
  • 0
  • 9
  • 0
  • -1
  • 0
  • 8
  • -2
  • 6
  • 2016 Q2
  • 474
  • -453
  • 21
  • -17
  • -2
  • 0
  • 4
  • 0
  • -3
  • 0
  • 1
  • -0
  • 1
  • 2016 Q3
  • 474
  • -442
  • 32
  • -19
  • -2
  • 0
  • 13
  • 0
  • -0
  • 0
  • 13
  • -1
  • 12
  • 2016 Q4
  • 605
  • -560
  • 45
  • -25
  • -1
  • 0
  • 20
  • 0
  • -4
  • 0
  • 16
  • -5
  • 11
  • 2017 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2017 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2017 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2017 Q1 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2017 Q2 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2017 Q3 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2017 Q4 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2018 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2018 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2018 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2018 Q1 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2018 Q2 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2018 Q3 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2018 Q4 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2019 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2019 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2019 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2019 Q1 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2019 Q2 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2019 Q3 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2019 Q4 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  

Estimated Values is behind membership

To access members-only content, you must login or register an account.

Our membership is about gaining access to unique research and knowledge through our analysts and a network of peers. Be the first to get information about news and research in the Nordic life science and technology sectors and use our tools and education to reach your personal and professional goals in investing.

Last updated: 2017-10-31 Source: Redeye
Source: Redeye

Presentations, research interviews and videos from our events listed here.


Source: Redeye

When selecting comparable companies, we try to group companies that are in the same or similar sector or subsector. But, more important, have growth, margins and risk characteristics similar to the company being valued.